Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia

[1]  Pratik Mukherjee,et al.  Diffusion tensor imaging segmentation of white matter structures using a Reproducible Objective Quantification Scheme (ROQS) , 2007, NeuroImage.

[2]  Andrew J. Saykin,et al.  Candidate mechanisms for chemotherapy-induced cognitive changes , 2007, Nature Reviews Cancer.

[3]  Qing Ji,et al.  A novel, fast entropy-minimization algorithm for bias field correction in MR images. , 2007, Magnetic resonance imaging.

[4]  Michael Noseworthy,et al.  White matter growth as a mechanism of cognitive development in children , 2006, NeuroImage.

[5]  K. Schmiegelow,et al.  High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia , 2006, Leukemia.

[6]  A. Kingma,et al.  Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, sibling-controlled study. , 2006, European journal of cancer.

[7]  P. Basser,et al.  A unifying theoretical and algorithmic framework for least squares methods of estimation in diffusion tensor imaging. , 2006, Journal of magnetic resonance.

[8]  Mark L. Greenberg,et al.  Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Chin-Shang Li,et al.  Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate. , 2006, Magnetic resonance imaging.

[10]  A. Veerman,et al.  Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor , 2006, Cancer.

[11]  Soonmee Cha,et al.  Partial‐volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas , 2006, Journal of magnetic resonance imaging : JMRI.

[12]  Pek-Lan Khong,et al.  White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Pui,et al.  Smaller white‐matter volumes are associated with larger deficits in attention and learning among long‐term survivors of acute lymphoblastic leukemia , 2006, Cancer.

[14]  B. Dan,et al.  Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features , 2006, Pediatric Radiology.

[15]  C. Pui,et al.  Treatment of acute lymphoblastic leukemia. , 2006, The New England journal of medicine.

[16]  P. Nathan,et al.  Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P , 2006, Leukemia & lymphoma.

[17]  C. Pui,et al.  A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. , 2005, AJNR. American journal of neuroradiology.

[18]  J. Hayakawa,et al.  Brain white matter changes during treatment of a child for acute lymphoblastic leukemia. , 2005, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[19]  A. Veerman,et al.  Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: Effect of treatment intensity , 2005, Pediatric blood & cancer.

[20]  C. Njiokiktjien,et al.  Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only , 2005, Journal of the International Neuropsychological Society.

[21]  R. Zimmerman,et al.  Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. , 2005, AJNR. American journal of neuroradiology.

[22]  E. Vandenbussche,et al.  Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only , 2005, Pediatric blood & cancer.

[23]  C. Pui,et al.  Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. , 2005, AJNR. American journal of neuroradiology.

[24]  T. Nägele,et al.  Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI , 2005, Journal of Neuro-Oncology.

[25]  N. Barrowman,et al.  Cognitive Changes in Children Treated for Acute Lymphoblastic Leukemia With Chemotherapy Only According to the Pediatric Oncology Group 9605 Protocol , 2005, Journal of child neurology.

[26]  Cara Reeves,et al.  Improving the segmentation of therapy‐induced leukoencephalopathy in children with acute lymphoblastic leukemia using a priori information and a gradient magnitude threshold , 2004, Magnetic resonance in medicine.

[27]  N. Winick,et al.  Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. , 2004, AJNR. American journal of neuroradiology.

[28]  Lucullus H. T. Leung,et al.  White-matter diffusion anisotropy after chemo-irradiation: a statistical parametric mapping study and histogram analysis , 2004, NeuroImage.

[29]  Winnie C W Chu,et al.  White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy. , 2003, Radiology.

[30]  Qing Ji,et al.  Prediction of total cerebral tissue volumes in normal appearing brain from sub-sampled segmentation volumes. , 2003, Magnetic resonance imaging.

[31]  M Wilke,et al.  Normative pediatric brain data for spatial normalization and segmentation differs from standard adult data , 2003, Magnetic resonance in medicine.

[32]  M. Tenner,et al.  Neurotoxicity of intrathecal methotrexate: MR imaging findings. , 2003, AJNR. American journal of neuroradiology.

[33]  E. Cook,et al.  Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Alejandro F Frangi,et al.  Automatic construction of 3-D statistical deformation models of the brain using nonrigid registration , 2003, IEEE Transactions on Medical Imaging.

[35]  V. Mok,et al.  Variability and Validity of a Simple Visual Rating Scale in Grading White Matter Changes on Magnetic Resonance Imaging , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[36]  Saara Totterman,et al.  Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI , 2003, Journal of magnetic resonance imaging : JMRI.

[37]  J. Jauhiainen,et al.  Perfusion MRI and SPECT of brain after treatment for childhood acute lymphoblastic leukemia. , 2003, Medical and pediatric oncology.

[38]  A. Hirt,et al.  Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences. , 2003, European journal of cancer.

[39]  Gal Sela,et al.  Utility of simultaneous brain, CSF and hyperintensity quantification in dementia , 2002, Psychiatry Research: Neuroimaging.

[40]  I. Yaniv,et al.  Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia. , 2002, The Israel Medical Association journal : IMAJ.

[41]  Derek K. Jones,et al.  Diffusion‐tensor MRI: theory, experimental design and data analysis – a technical review , 2002, NMR in biomedicine.

[42]  K. Krishnan,et al.  Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects , 2002, Psychiatry Research: Neuroimaging.

[43]  W. Reddick,et al.  Quantitative MRI assessment of leukoencephalopathy , 2002, Magnetic Resonance in Medicine.

[44]  D. W. Desmond.  Cognition and White Matter Lesions , 2002, Cerebrovascular Diseases.

[45]  K. Zou,et al.  Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy , 2002, Journal of magnetic resonance imaging : JMRI.

[46]  A. Kingma,et al.  Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. , 2001, The Journal of pediatrics.

[47]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.

[48]  E. Pääkkö,et al.  White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. , 2000, Medical and pediatric oncology.

[49]  Barkovich Aj.  Concepts of Myelin and Myelination in Neuroradiology , 2000 .

[50]  M. Elmaleh,et al.  Contribution of single-photon emission computed tomography in the diagnosis and follow-up of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  S Warach,et al.  A general kinetic model for quantitative perfusion imaging with arterial spin labeling , 1998, Magnetic resonance in medicine.

[52]  N. Winick,et al.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  Edwin N. Cook,et al.  Automated segmentation and classification of multispectral magnetic resonance images of brain using artificial neural networks , 1997, IEEE Transactions on Medical Imaging.

[54]  T. Bottiglieri,et al.  Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  M. Skalej,et al.  CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group. , 1997, Medical and pediatric oncology.

[56]  Y. Yazaki,et al.  Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. , 1997, Circulation.

[57]  J. Ross,et al.  Epidemiology of acute leukemia in children and adults. , 1997, Seminars in oncology.

[58]  D. Francis,et al.  Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  E. Pääkkö,et al.  Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia , 1996, Neuroradiology.

[60]  David Katz,et al.  The relation between brain iron and NMR relaxation times: An in vitro study , 1996, Magnetic resonance in medicine.

[61]  W. Bleyer.  Leukoencephalopathy detectable by magnetic resonance imaging: much ado about nothing? Regarding Matsumoto et al. IJROBP 32:913-918; 1995. , 1995, International journal of radiation oncology, biology, physics.

[62]  R. Butler,et al.  Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  L Bolinger,et al.  Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. Kingma,et al.  Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. , 1993, The American journal of pediatric hematology/oncology.

[65]  E. Pääkkö,et al.  White matter changes in children treated for acute lymphoblastic leukemia , 1992, Cancer.

[66]  S. Sexson,et al.  Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae. , 1992, The Journal of pediatrics.

[67]  Yukio Miki,et al.  Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate , 1992, Cancer.

[68]  R. Mulhern,et al.  Long-term survivors of leukemia treated in infancy: factors associated with neuropsychologic status. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  Donald S. Williams,et al.  Magnetic resonance imaging of perfusion using spin inversion of arterial water , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Stevens,et al.  Cognitive effects of childhood leukemia therapy: a case for four specific deficits. , 1991, Journal of pediatric psychology.

[71]  J. R. Prince,et al.  Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. , 1991, Radiology.

[72]  D. Oshman,et al.  Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia , 1991, Cancer.

[73]  P. Ueland,et al.  Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. , 1991, Cancer research.

[74]  R. Packer,et al.  Acute mental status changes in children with systemic cancer. , 1990, Pediatrics.

[75]  G. Wahba.  Spline Models for Observational Data , 1990 .

[76]  Professor Dr. Jacob Valk,et al.  Magnetic Resonance of Myelin, Myelination, and Myelin Disorders , 1989, Springer Berlin Heidelberg.

[77]  R. Mulhern,et al.  Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  G. Rosen,et al.  Transient cerebral dysfunction secondary to high-dose methotrexate. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  P. Fedio,et al.  Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. , 1985, The Journal of pediatrics.

[80]  J. Fletcher,et al.  Neuropsychological sequelae of childhood cancer in long-term survivors. , 1985, Pediatrics.

[81]  W. Bowman,et al.  SEIZURES IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA PATIENTS , 1984, The Lancet.

[82]  J. Holland,et al.  Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  W. Bowman,et al.  Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  M. Alexander,et al.  Principles of Neural Science , 1981 .

[85]  P. F. Cooper,et al.  Distractibility and Memory Deficits in Long‐Term Survivors of Acute Lymphoblastic Leukemia , 1980, Journal of developmental and behavioral pediatrics : JDBP.

[86]  G. di Chiro,et al.  Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. , 1979, The New England journal of medicine.

[87]  D. Fischer,et al.  Intracranial calcifications in childhood leukemia , 1977 .

[88]  A. Trowbridge,et al.  Idiopathic acquired sideroblastic anemia terminating in acute myelofibrosis. Case report and review of literature , 1977, Cancer.

[89]  A. Evans,et al.  Effects of chemotherapy on the central nervous system—A study of parenteral methotrexate in long‐term survivors of leukemia and lymphoma in childhood , 1976, Cancer.

[90]  B. Smith.  BRAIN DAMAGE AFTER INTRATHECAL METHOTREXATE , 1975, Journal of neurology, neurosurgery, and psychiatry.

[91]  G. Paolucci,et al.  [Treatment of acute lymphoblastic leukemia]. , 1971, Minerva pediatrica.

[92]  R. Mulhern,et al.  Structural Abnormalities in Posterior Fossa Brain Tumor Survivors : a Voxel-Based Morphometry Study Based on Free-Form Deformation , 2005 .

[93]  M. Gorman,et al.  Diffusion-Weighted MRI Correlates of Subacute Methotrexate-Related Neurotoxicity , 2005, Journal of Neuro-Oncology.

[94]  P. Khong,et al.  White-matter diffusion anisotropy after chemoirradiation in medulloblastoma survivors: voxel-based analysis and histogram study , 2004 .

[95]  P. Wen,et al.  Neurologic complications of cancer therapy. , 2003, Neurologic clinics.

[96]  A. Barkovich.  Concepts of myelin and myelination in neuroradiology. , 2000, AJNR. American journal of neuroradiology.

[97]  P. Uvebrant,et al.  Studies of cerebral blood flow in children with acute lymphoblastic leukemia: case reports of six children treated with methotrexate examined by single photon emission computed tomography. , 1997, Journal of pediatric hematology/oncology.

[98]  B. M. Lanning,et al.  Brain perfusion after treatment of childhood acute lymphoblastic leukemia. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[99]  J. Connor,et al.  Relationship of iron to oligodendrocytes and myelination. , 1996, Glia.

[100]  PhD Marjo S. van der Knaap MD,et al.  Magnetic Resonance of Myelin, Myelination, and Myelin Disorders , 1995, Springer Berlin Heidelberg.

[101]  S. Bakke,et al.  Long-term cerebral effects of CNS chemotherapy in children with acute lymphoblastic leukemia. , 1993, Pediatric hematology and oncology.

[102]  R. Mulhern,et al.  Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  L. Robison,et al.  Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study. , 1991, Medical and pediatric oncology.

[104]  D. Poplack,et al.  Memory and Learning Sequelae in Long‐term Survivors of Acute Lymphoblastic Leukemia: Association with Attention Deficits , 1990, The American journal of pediatric hematology/oncology.

[105]  J. Ochs,et al.  Neurotoxicity due to central nervous system therapy for childhood leukemia. , 1989, The American journal of pediatric hematology/oncology.

[106]  C. Pui,et al.  High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X. , 1988, Medical and pediatric oncology.